- Home
- IMRN vs NCRA Comparison
IMRN vs NCRA Comparison
Compare IMRN & NCRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRN
- NCRA
- Stock Information
- Founded
- IMRN 1994
- NCRA 2002
- Country
- IMRN Australia
- NCRA Taiwan
- Employees
- IMRN N/A
- NCRA N/A
- Industry
- IMRN Biotechnology: Pharmaceutical Preparations
- NCRA Farming/Seeds/Milling
- Sector
- IMRN Health Care
- NCRA Consumer Staples
- Exchange
- IMRN Nasdaq
- NCRA Nasdaq
- Market Cap
- IMRN 15.0M
- NCRA 12.6M
- IPO Year
- IMRN N/A
- NCRA N/A
- Fundamental
- Price
- IMRN $2.11
- NCRA $0.93
- Analyst Decision
- IMRN Strong Buy
- NCRA
- Analyst Count
- IMRN 1
- NCRA 0
- Target Price
- IMRN $5.00
- NCRA N/A
- AVG Volume (30 Days)
- IMRN 6.2K
- NCRA 8.0K
- Earning Date
- IMRN 12-31-2024
- NCRA 08-14-2024
- Dividend Yield
- IMRN N/A
- NCRA N/A
- EPS Growth
- IMRN N/A
- NCRA N/A
- EPS
- IMRN N/A
- NCRA N/A
- Revenue
- IMRN $3,271,194.00
- NCRA $20,483,694.00
- Revenue This Year
- IMRN N/A
- NCRA N/A
- Revenue Next Year
- IMRN N/A
- NCRA N/A
- P/E Ratio
- IMRN N/A
- NCRA N/A
- Revenue Growth
- IMRN 171.67
- NCRA N/A
- 52 Week Low
- IMRN $1.59
- NCRA $0.70
- 52 Week High
- IMRN $5.96
- NCRA $1.54
- Technical
- Relative Strength Index (RSI)
- IMRN 52.87
- NCRA 45.05
- Support Level
- IMRN $2.05
- NCRA $0.70
- Resistance Level
- IMRN $2.23
- NCRA $1.14
- Average True Range (ATR)
- IMRN 0.16
- NCRA 0.10
- MACD
- IMRN 0.02
- NCRA -0.01
- Stochastic Oscillator
- IMRN 47.06
- NCRA 51.40
About IMRN Immuron Limited
Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
About NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with expert consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.